This CAF-induced CRC cell migration can be blocked by knocking down FASN in CAFs in vitro or by impeding fatty acid uptake by CRC cells using a CD36 monoclonal antibody in vivo [135]. This evidence concerns the gene CD36 and colorectal carcinoma.